✦ LIBER ✦

Exam 2: Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B

Book ID: 123509882
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 81 KB
Volume: 10
Category: Article
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2012.06.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Similar Risk of Renal Events Among Patie

✍ Gish, Robert G.; Clark, Margaret D.; Kane, Steve D.; Shaw, Richard E.; Mangahas, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 269 KB

P1049 RISK FACTORS FOR HEPATOCELLULAR CA

P1049 RISK FACTORS FOR HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH ENTECAVIR

✍ Yamada, R.; Hiramatsu, N.; Morishita, N.; Harada, N.; Oze, T.; Yakushijin, T.; M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

1011 RISK AND PREDICTORS OF MORTALITY OR

1011 RISK AND PREDICTORS OF MORTALITY OR HEPATOCELLULAR CARCINOMA AMONG ENTECAVIR- OR ADEFOVIR-TREATED CHRONIC HEPATITIS B PATIENTS WITH EVIDENCE OF HEPATIC DECOMPENSATION

✍ Liaw, Y.-F.; Raptopoulou-Gigi, M.; Cheinquer, H.; Sarin, S.K.; Tanwandee, T.; Le 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB

M1897 Risk and Predictors of Mortality o

M1897 Risk and Predictors of Mortality or Hepatocellular Carcinoma Among Entecavir- or Adefovir-Treated Chronic Hepatitis B Patients With Evidence of Hepatic Decompensation

✍ Tsai, Naoky; Liaw, Yun-Fan; Raptopoulou-Gigi, Maria; Cheinquer, Hugo; Sarin, Shi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Biochemical and virological outcome of p

Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients

✍ E K Manesis; C Papaioannou; A Gioustozi; G Kafiri; J Koskinas; S J Hadziyannis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

To compare two interferon (IFN) schedules for the treatment of chronic hepatitis C, we followed 211 patients who received 3 million units IFN-alpha2b thrice weekly for either 6 months (group 1; 85 patients) or 12 months (group 2; 126 patients), with a median follow-up of 3.4 (0.1-8.4) and 4.2 (0.7-8

Biochemical and virological outcome of p

Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients

✍ EK Manesis; C Papaioannou; A Gioustozi; G Kafiri; J Koskinas; SJ Hadziyannis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB